{"id":"NCT01646255","sponsor":"UCB Pharma","briefTitle":"Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients","officialTitle":"A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Study of The Efficacy And Safety of Rotigotine Transdermal Patch In Chinese Subjects With Advanced-stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled On Levodopa","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-07","primaryCompletion":"2014-10","completion":"2014-10","firstPosted":"2012-07-20","resultsPosted":"2016-01-22","lastUpdate":"2018-04-04"},"enrollment":346,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Idiopathic Parkinson's Disease"],"interventions":[{"type":"DRUG","name":"Rotigotine","otherNames":[]},{"type":"DRUG","name":"Placebo Patch","otherNames":[]},{"type":"DRUG","name":"L-dopa","otherNames":["Levodopa"]}],"arms":[{"label":"Rotigotine","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The primary objective of this study was to demonstrate that Rotigotine transdermal patch is efficacious in Chinese subjects with advanced-stage Idiopathic Parkinson's Disease as an adjuvant therapy.","primaryOutcome":{"measure":"Absolute Change in Absolute Time Spent 'Off' From Baseline to the End of Double-blind Maintenance Period","timeFrame":"From Baseline (Week 0) to end of Maintenance Period (up to Week 12)","effectByArm":[{"arm":"Full Analysis Set (Placebo Treated Subjects)","deltaMin":-1.13,"sd":3.2},{"arm":"Full Analysis Set (Rotigotine Treated Subjects)","deltaMin":-2.36,"sd":2.83}],"pValues":[{"comp":"OG000 vs OG001","p":"=0.0002"}]},"eligibility":{"minAge":"30 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":20},"locations":{"siteCount":24,"countries":["China"]},"refs":{"pmids":["28827011"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":172},"commonTop":["Dizziness","Pruritus","Nausea","Dyskinesia"]}}